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Introduction
Valid and reliable measurement of cardiovascular responses to ex-
ercise is a frequent necessity for exercise physiologists. For exam-
ple, evaluations of heart rate (HR), stroke volume (SV), cardiac out-
put (Q̇) and blood pressure (BP) are often conducted across sepa-
rate days of an investigation [6, 16]. Singular measurements of 
these parameters, such as BP, are recorded routinely in practice 
using auscultatory or oscillatory methods; however, continuous 
measurements of BP have been developed over the past ~ 20 years 
[25]. These methods improve upon the traditional continuous ap-
proaches, which require invasive procedures [22]. Continuous 
measurements of BP are applicable to studies that aim to identify 
acute changes in BP across time, as well as transient fluctuations in 
BP that might occur during a resting or exercising bout. The most 
recognizable criterion approach to measuring these variables con-
tinuously is the intra-brachial (within-artery) method, requiring an 
invasive cannulation of the artery, which is not always practical, 
safe or warranted in an exercising participant. Owing to these lim-
itations, an alternative, non-invasive approach has been to meas-
ure finger-pulse pressure [25].
The so-called finger-clamp method has been adopted for non-
invasive continuous measurements of BP [25]. This approach main-
tains the diameter of a measured finger artery using a small inflat-
able cuff. The cuff restricts any initial change in the arterial radius, 
identified by infrared photoplethysmography throughout each suc-
cessive cardiac cycle [4]. The inevitable changes in intra-arterial 
pressure are counteracted, and thus inferred, from the recorded 
extramural tissue pressure (i. e. from the cuff) [25]. Of further in-
Waldron Mark et al. Inter-Day Reliability of Finap- res® … Sports Medicine International Open 2017; 00: 00–00
Inter-Day Reliability of Finapres® Cardiovascular Measurements 
During Rest and Exercise
  
Authors
Mark Waldron1, 2, Stephen David Patterson1, Owen Jeffries1
Affiliations
1  St Mary's University Twickenham London, School of 
Sport, Health and Applied Sci, London, United Kingdom 
of Great Britain and Northern Ireland
2  School of Science and Technology, University of New 
England, NSW, Australia.
Key words
Measurement error, blood pressure, cardiac
received  03.08.2017 
revised  02.10.2017 
accepted  13.10.2017
Bibliography
DOI https://doi.org/10.1055/s-0043-122081
Sports Medicine International Open 2018; 2: E9–E15
© Georg Thieme Verlag KG Stuttgart · New York 
ISSN 2367-1890
Correspondence
Dr. Mark Waldron, PhD
St Mary's University Twickenham London
School of Sport, Health and Applied Sci
Waldegrave Road
London, TW14SX
United Kingdom of Great Britain and Northern Ireland
Tel.:  + 44/20/8240 4062, Fax:  + 44/20/8240 4062 
mark.waldron@stmarys.ac.uk
AbStr Act
This study evaluated the inter-day test-retest reliability of the 
Finapres® finger pulse pressure measuring device during rest 
and exercise. Eight male participants visited the laboratory 
twice for evaluation of the inter-day reliability of the Finapres® 
finger-pulse pressure device to measure: heart rate (HR), stroke 
volume (SV), cardiac output (Q̇) and mean arterial pressure 
(MAP) at rest, and treadmill walking at 3 km/h on 1 % and 5 % 
inclines. There were no systematic biases for any of the variables 
between days. The coefficient of variation (CV %) and 95 % limits 
of agreement (95 % LoA) was smallest for MAP (CV % = 1.6–3.2 %; 
LoA total error = 4.6–12 mmHg) and HR (CV % = 3.2–3.9 %; LoA 
total error = 6.8–11.9 b/min), increasing with exercise intensity 
(gradient). The pattern of error was different for Q̇, with de-
creasing CV % (4.8–3.8 %) and LoA (4.2–5.7 L/min) from rest to 
5 % gradient, with the larger errors occurring for resting SV 
(CV = 7.4 %; LoA total error = 21.5 ml). The device measures MAP 
and HR reliably between days; however, error increases at 
higher intensities. The measurement of SV is less reliable, prob-
ably owing to underlying algorithmic assumptions.
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terest to the exercise science community are the reconstruction of 
brachial arterial pressure from the finger-pulse pressure waveform 
and the calculation of cardiovascular parameters that are relevant 
to exercise performance, such as SV, HR and Q̇ [4].
Continuous finger-pulse pressure measurements have been com-
pared to criterion intra-arterial methods with mixed results. Collec-
tively, research has demonstrated that non-invasive finger-pulse 
measurements (i. e. Finapres® device, TNO Biomedical Instrumen-
tation, Amsterdam, Netherlands) overestimate criterion methods 
by between ~ 5 mmHg [17] and 20 mmHg [5, 20] but appear to be 
much closer based on meta-analysed datasets with a mean bias of ~ 
1.6 and random error of ± 7.7 mmHg for mean arterial pressures [9]. 
This was within the suggested mean bias of 5 mmHg and random 
error of ± 8 mmHg suggested by the Association for Advancement 
of Medical Instrumentation (AAMI) [28]. Whilst the criterion validity 
of the Finapres® has been well-investigated, its reliability between 
laboratory visits has not been reported among healthy, normoten-
sive participants. What is more, its reliability during light-to-moder-
ate exercise intensities has not been evaluated, which is necessary 
given its application to exercising subjects [8]. Therefore, the aim of 
this study was to evaluate the inter-day test-retest reliability of the 
Finapres® finger pulse blood pressure measuring device during rest 
and light-moderate exercise among healthy normotensive volun-
teers. The a-priori analytical goal was to report mean bias and agree-
ment between days within that suggested by the AAMI.
Methods
Participants and design
Eight recreationally active male participants (age 27 ± 4 years; body 
mass 74.4 ± 10.3 kg; stature 172.8 ± 6.2 cm; MAP 104.4 ± 4.4 mmHg) 
provided written informed consent to take part in this study, which 
was given institutional ethical approval. The participants visited 
the laboratory on three occasions at the same time of day for fa-
miliarisation (visit 1) and inter-day reliability tests over visits 2 and 
3. Each visit was separated by 24 h. The participants refrained from 
exercise in the 48 h before any of their visits and were also instruct-
ed to abstain from caffeine, foods high in dietary nitrate and alco-
hol consumption during this period. A list of foods and beverages 
were provided to assist with this. This study was granted institu-
tional ethical approval and was undertaken in compliance with the 
ethical guidelines of Harriss and Atkinson [7].
Procedure
Familiarisation
On their first visit to the laboratory, the participants completed a 
familiarisation trial, where they were screened for their capacity to 
perform moderate exercise using the Exercise and Sports Science 
Australia (ESSA) risk stratification procedure. This included record-
ing of their blood pressure, both with a manual sphygmomanom-
eter and with the Finapres® device (Finometer MIDI, TNO Biomed-
ical Instrumentation, Amsterdam, Netherlands). All measurements 
were performed by an ESSA-accredited and experienced exercise 
physiologist. The participants were taken through the exercise trial 
and instrumented in the same way that they would be on their sub-
sequent visits. A food diary was completed at their familiarisation 
visit, which was replicated for visits 2 and 3.
Reliability trials
The two following visits were performed to evaluate the test re-
test reliability of the Finapres® device during rest and 2 min of ex-
ercise at a fixed speed (3 km/h) up 1 % and 5 % gradients (in that 
order) on a motorised treadmill (Mercury® Med, hpcosmos sports 
& medical gmbh; Nussdorf-Traunstein, Germany). This mode of ex-
ercise was selected because it partially mimics stress tests per-
formed by clinical exercise physiologists and involves minimal 
movement of the arms to which the device was subsequently fit-
ted. Participants reported to the laboratory at approximately 
0900 h each day, 2-h post-prandial, having consumed at least 
500 ml of fluid that morning. The same fluid was consumed each 
day, as per their food diary. After seated rest for 20 min, the partic-
ipants were asked to stand on the treadmill, where they were fit-
ted with the Finapres® device. The laboratory was controlled at 
20.0 ± 0.8 ˚ C and 45 ± 10 % relative humidity.
The Finapres® device was fitted to the left arm of each partici-
pant. Specifically, the device was fitted by securing an inflatable 
plastic bladder (50 µm and 55 mm length) between the distal and 
proximal inter-phalangeal joint of the middle finger, which housed 
an infrared light-emitting diode (950 nm emission) and detector. 
This was connected to a front-end unit via an air hose. The front-
end unit was attached to the left wrist using a Velcro strap. The 
front end is connected to the main unit and pump inside the Finom-
eter MIDI. A height correction unit was also fitted to the front-end 
unit to automatically correct for hydrostatic pressure changes due 
to movement in the hand position relative to the heart. During the 
walking trials, the participants walked with a natural arm carriage, 
with their fingers relaxed and without holding on to the treadmill. 
A laptop was connected to the Finometer MIDI and the raw data 
were analysed using the BeatScope® software (Version 1.1, Finap-
res Medical Systems BV, Arnhem, Netherlands). BeatScope® soft-
ware was used to reconstruct mean brachial arterial pressure from 
the finger-pulse pressure waveform and calculate stroke volume, 
heart rate and cardiac output at rest and during exercise using pat-
ented Modelflow® algorithms. In brief, the Modelflow® algorithm 
is used to measure SV from the integral of the pulsatile area of the 
systolic segment of the pressure waveform [22]. Age, gender, body 
mass and stature were entered into the software for each partici-
pant. The exercise comprised walking at 1 % and 5 % gradients for 
a period of 2 min, each separated by 5 min of standing. The Finap-
res® was activated 1 min prior to recording to allow for calibration. 
The calibration is performed automatically using the Physiocal soft-
ware in the device, which was deactivated during the 2-min trials 
to prevent interruption of the recording. No further filtering was 
applied to the data.
The Finapres® device uses the finger-clamp method, whereby 
the diameter of the finger artery under the cuff is maintained at a 
constant whilst changes in intra-arterial pressure occur during the 
cardiac cycle [22]. Initial fluctuations in diameter are measured via 
an infrared photoplethysmograph, which sits within the inflatable 
finger cuff. The finger cuff applies the necessary counter-pressure 
(extramural) during monitoring via a rapid-pressure servo-control-
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ler system, in response to the plethysmograph signal to prevent 
any volume change [4]. This dynamic process alters the character-
istics of the underlying artery from a pulsating, variable-sized di-
ameter to a non-pulsating (constant) smaller state. When record-
ed extramural tissue pressure (i. e. from the cuff) matches intra-ar-
terial pressure, then the transmural (dif ference between 
extramural and intra-arterial) pressure is zero [25] and finger pres-
sure can be inferred. An in-built programme (Physiocal, Finometer 
Medical Systems, Amsterdam, Netherlands) acted as a calibration 
system, ensuring that the arterial diameter set-point remained con-
stant [10, 11]. Left ventricular stroke volume was estimated from 
the integral of the arterial pressure flow-wave, with the aortic cross-
section assumed and adjusted for age, gender, height and body 
mass of the participants [14]. Instantaneous heart rate measure-
ments were multiplied by SV to derive Q̇.
Statistical analysis
Two methods were used to evaluate the inter-day reliability of the 
Finapres® device for measuring MAP, HR, SV and Q̇; the 95 % limits 
of agreement (95 % LOA, [3]) and the coefficient of variation (CV; 
[1]). The ratio limits of agreement (95 % ratio LOA, [1]) were used 
to account for heteroscedastic errors but were reported in all cases 
for comparative purposes. Data were initially checked for normal-
ity of differences using the Shapiro-Wilk test. Further checks for 
heteroscedastic errors were carried out using Pearson product–
moment correlation (r-value). Paired samples t-tests were used to 
calculate differences (biases) between day 1 and day 2 of the trial. 
References to total error refer to the combination of the systemat-
ic and random errors calculated using the 95 % LoA technique. Sta-
tistical significance was set at P < 0.05. Data are reported as 2-min 
averages and standard deviations throughout and analysed using 
SPSS (v.24; SPSS Inc., Chicago, IL, USA).
Results
There were no heteroscedastic errors or systematic biases for any 
of the variables between visit 1 and visit 2 (P > 0.05) (▶Figs. 1– 4).
The CV % was smallest for MAP, ranging from 1.6–3.2 % as a func-
tion of exercise intensity (gradient). Similarly, the CV % of heart rate 
increased from 3.4 to 3.9 % from rest to 5 % exercising gradient. The 
pattern of error was different for other variables, with either de-
creasing Q̇ CV % from rest to 5 % gradient (4.8 to 3.8 % respectively) 
or larger (7.4 % CV) and less predictable errors in SV (▶table 1).
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▶Fig. 1 Mean 2-min arterial pressure (mmHg) (mean ± SD) during 
visit 1 and 2. A = rest; B = 1 % gradient; C = 5 % gradient.
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▶Fig. 2 Mean 2-min heart rate (b/min) (mean ± SD) during visit 1 
and 2. A = rest; B = 1 % gradient; C = 5 % gradient.
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The 95 % LoA confirmed the pattern of error identified with CV % 
but accounted for a larger portion of the sample. The largest error 
between days was the resting stroke volume, which was 6.1 ml high-
er on visit 2, with a total error of 21.5 ml. For mean arterial pressure, 
the mean biases were small (0.1 to 1.6 mmHg), with random error 
reaching 11.1 mmHg at the 5 % gradient (total error = 12 mmHg). 
Cardiac output demonstrated consistent total errors of ~ 1 L/min 
across all conditions, with the largest error occurring in the resting 
condition (–0.4 ± 0.7 L/min), which was explained by the larger 
 errors in stroke volume during rest (▶table 1).
Discussion
The main findings of this study were that the inter-day error of the 
Finapres® device for measuring mean arterial brachial pressure was 
within the total error range of the analytical goal (5 mmHg mean 
bias and 8 mmHg random error = 13 mmHg) suggested by the AAMI 
at rest and during treadmill walking exercise. The mean bias was 
below the recommended 5 mmHg in all cases but the random error 
was increased by the inclusion of larger biases (~ 11.1 mmHg) in 
the 5 % gradient condition. All of the statistical techniques used 
herein indicated that the MAP and HR error was increased as a func-
tion of the exercise intensity (i. e. rest through to gradients of 5 %). 
The more lenient CV % technique [1] agreed with this pattern, dem-
onstrating errors of 1.6 %, 1.9 % and 3.9 % for MAP and 3.4 %, 3.5 % 
and 3.9 % for HR (▶table 1). Measurements of BP and HR are re-
corded in a more direct manner by the Finapres® device, either 
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▶Fig. 3 Mean 2-min cardiac output (L/min) (mean ± SD) during visit 
1 and 2. A = rest; B = 1 % gradient; C = 5 % gradient
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▶Fig. 4 Mean 2-min stroke volume (ml) (mean ± SD) during visit 1 
and 2. A = rest; B = 1 % gradient; C = 5 % gradient.
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from the cuff pressure or the pulse identification, respectively. 
Given that the other parameters rely on secondary calculations and 
a variety of assumptions, it is possible that the increases in errors 
of other variables, such as SV, are explained by additional factors. 
The largest reported CV was 7.4 % (resting SV). Collectively, our 
findings provide encouraging evidence for the capacity of the Fi-
napres® device to continuously measure a variety of cardiovascu-
lar responses to rest and exercise, particularly given the potential 
for biological variation between days.
The Modelflow® algorithm [26], used to measure SV, is a devel-
opment of the original corrected impedance (cZ) method [27]. As-
suming constant impedance (Z) based on age and MAP, this ap-
proach uses the systolic segment of the pressure waveform to cal-
culate SV from the integral of the so-called pulsatile area (PSA). This 
was subsequently updated [26] with a 3-element Windkessel 
model. It was recognised that systolic flow is dependent upon ar-
terial impedance as well as compliance and peripheral resistance 
[4]. Therefore, these three components are accounted for in the 
current Modelflow® method, dependent upon age, gender, stat-
ure and body mass [22]. These processes permit the production of 
a flow wave, which is integrated to compute SV and multiplied with 
HR to yield Q̇. Accordingly, the model makes numerous assump-
tions regarding the dynamics of the impedance and compliance of 
cardiovascular structures that are incorporated, such as the main 
arteries (aorta and brachial artery). For example, it assumes an ‘av-
erage’ aorta structure and function of connecting valves based on 
autopsied human tissue [14], which might not reflect the size and 
elastic properties of the current sample. This is particularly relevant 
under exercising conditions, where the pressor reflex is responsi-
ble for altering peripheral resistance via vasoconstriction of periph-
eral vasculature, which will consistently vary depending upon the 
degree of metabolic and mechanical afferent feedback [13]. In-
deed, the additional mechanical movement and metabolic demand 
required to walk at a 5 % gradient might explain the more variable 
MAP response compared to 1 % or resting values. Modelflow® also 
assumes that aortic pressure is unaffected by pulmonary hyperin-
flation or changes in intra-abdominal pressure [4]. These changes 
are typically observed in the exercising athlete and are unlikely to 
be consistent between trials. Lastly, the assumed aortic properties 
that inform the Modelflow® algorithm were based on subjects rang-
ing from 30 to 88 years of age, which does not reflect that of the 
current study (27 ± 4 years). This will primarily affect the agreement 
with criterion SV and Q̇ measurements (see validity studies [18]) 
because the models outputs are based on the less compliant and 
elastic properties of arteries of older subjects. However, these as-
sumptions are also likely to affect the reliability between trials. This 
is because Modelflow® approximates the maximal cross-sectional 
area of the aorta based on the same autopsy data, despite the well-
known variable increases in aortic flow and pressure as a function 
of exercise intensity [21]. This combination of factors provides rea-
sons for the poorer reliability of SV measurements in this study. 
Measurements of Q̇ appear to be salvaged by the more reliable HR 
recording, which is multiplied by SV to provide these data.
It has been suggested that finger pulse pressure measurements 
should be conducted over ‘optimal’ periods of time, ranging be-
tween 30 s [17] and 30 min [9]. Indeed, the 2-min period of BP re-
cording in the current study was partly based upon these recom-
mendations. These suggestions appear to be based on the follow-
ing reasons: First, it has been reported that finger-pulse pressure 
measurements drift over extended periods of time (3–4 h), which 
is attributed to the mechanical distortion of the underlying tissues 
and might require participants to remove the cuff to establish base-
line blood flow [19]. Secondly, periods shorter than 30 s are thought 
to produce erroneous data, owing to the relative contribution of 
anomalous data points to the entire data array across brief time 
periods [17]. The reasons for erroneous data points in this study 
are difficult to identify; however, this could be explained by the in-
creased exercise intensity and subsequent fluctuation in centre of 
mass and limb movement. The Finapres® can be sensitive to sud-
den movement of the limb-fitted hardware on the participant, 
▶table 1 The inter-day reliability of resting mean arterial pressure, heart rate, stroke volume and cardiac output during rest, walking at 1 % and 5 % gradi-
ents on a treadmill (n = 7).
resting 1 % gradient 5 % gradient
Mean arterial pressure
CV % ± 95 % CIs 1.6 ± 0.2 1.9 ± 0.3 3.2 ± 0.3
95 % LoA (mmHg) –0.1 ± 4.5 –1.6 ± 5.7 –0.9 ± 11.1
95 % ratio LoA 1.01 × / ÷ 1.04 1.01 × / ÷ 1.1 1.01 × / ÷ 1.09
Heart rate
CV % ± 95 % CIs 3.4 ± 0.4 3.5 ± 0.4 3.9 ± 0.5
95 % LoA (b/min) 0.5 ± 6.3 1.8 ± 7.8 –0.6 ± 11.3
95 % ratio LoA 1.01 × / ÷ 1.10 1.02 × / ÷ 1.11 1.01 × / ÷ 1.10
Stroke volume
CV % ± 95 % CIs 7.4 ± 0.9 4.0 ± 0.5 5.8 ± 0.7
95 % LoA (ml) –6.1 ± 15.4 –1.2 ± 9.6 –1.8 ± 14.1
95 % ratio LoA 1.09 × / ÷ 1.21 1.10 × / ÷ 1.1 1.02 × / ÷ 1.17
cardiac output
CV % ± 95 % CIs 4.8 ± 0.9 3.9 ± 0.4 3.8 ± 0.4
95 % LoA (L/min) –0.4 ± 0.7 0.1 ± 0.8 –0.2 ± 1.0
95 % ratio LoA 1.08 × / ÷ 1.13 1.01 × / ÷ 1.10 1.03 × / ÷ 1.10
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causing motion artefacts [23]. The type of exercise used (low-in-
tensity incline walking) negates some of these issues, but higher 
intensities or the introduction of more dynamic movements may 
be problematic.
Other studies have reported s higher variation in the mean ar-
terial pressure, measured via a manual brachial sphygmomanom-
eter (CV = 4.78 %) or finger pulse pressure (13.44 %) [24]. This vari-
ation was unanticipated, given that the study was conducted on 
resting participants and used the same finger pulse pressure de-
vice. However, our study attempted to control for diet and hydra-
tion prior to each visit, both of which can affect haemodynamic re-
sponses. Furthermore, we did not apply any other form of occlu-
sion to a limb during the study, whereas Wecht et al. [24] performed 
a concurrent manual BP measurement using a sphygmomanom-
eter, which is also likely to inconsistently disrupt BP in the contralat-
eral limb between visits [15]. These reasons might explain the dis-
crepancies between studies.
Studies attempting to investigate the reliability of finger-pulse 
pressure devices have overlooked inter-day reliability [5, 12, 18]. In 
the exercise sciences, it is common to adopt within-participant 
crossover research designs, whereby participants are randomised 
into experimental conditions across days of a study. In this instance, 
it is imperative that researchers understand the noise associated 
with a device between visits to the laboratory under controlled con-
ditions [1]. To facilitate the use of this device among researchers, 
we have used the nomogram of Batterham and Atkinson [2] and 
the reliability values reported therein to estimate sample sizes for 
each of the four measured variables that would be necessary to de-
tect 5 % changes. The highest sample sizes needed would be 7 and 
8 for MAP and HR, respectively, whilst SV and Q̇ would require 44 
or 20 participants, respectively, to detect the same 5 % signal 
change. In the absence of position statements about the accept-
able error for HR, SV and Q̇, we encourage users to develop a-pri-
ori analytical goals that are specific to their study and note the 
above sample sizes prior to using this device for research purposes.
Conclusion
The Finapres® device measures both MAP and HR reliably between 
consecutive visits to the laboratory, which would permit the detec-
tion of at least 5 % changes with relatively small samples of 7–8 par-
ticipants. The error appeared to increase as a function of exercise 
intensity for HR and MAP, which might relate to the movement of 
the hardware. The measurement of SV and, to a lesser degree Q̇, 
was less reliable and would require much larger sample sizes to 
 detect changes that might be anticipated owing to an intervention. 
The reason for these errors is likely to relate to the assumptions of 
the Modelflow® algorithm.
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